Clinical Trials Browser

INDUSTRY × Zoledronic Acid × Breast × Clear all

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase 3 Completed

3,420 enrolled 19 charts

Breast Neoplasms

NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Phase 3 Completed

2,049 enrolled 16 charts

Breast Neoplasms, Fractures, Bone

NCT00424983 2020-12-21

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

Phase 1 Completed

BreastPlasma cell

Breast Neoplasms, Multiple Myeloma

NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Phase 2 Completed

43 enrolled 10 charts

Bone Diseases, Breast Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT00334139 2017-02-07

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT00333229 2014-11-25

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Phase 4 Terminated

11 enrolled 6 charts

Breast Neoplasms

NCT00320710 2014-08-22

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Phase 3 Completed

416 enrolled 10 charts

Breast Neoplasms

NCT00060138 2013-05-15

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Phase 1/2 Completed

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

NCT00171340 2012-04-16

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase 3 Completed

1,065 enrolled 10 charts

Bone Diseases, Metabolic, Breast Neoplasms

NCT00171314 2012-04-11

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Phase 3 Completed

527 enrolled 11 charts

Breast Neoplasms

NCT00375427 2012-04-11

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Phase 3 Completed

430 enrolled 12 charts

Breast Neoplasms

NCT00029224 2012-02-01

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Phase 4 Completed

BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

NCT00332709 2011-11-16

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Phase 3 Completed

83 enrolled 14 charts

Breast Neoplasms, Osteoporosis

NCT00372710 2009-11-23

Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions

Phase 3 Terminated

Breast Neoplasms